Isocyanides as Influenza A Virus Subtype H5N1 Wild-Type M2 Channel Inhibitors

ChemMedChem. 2015 Nov;10(11):1837-45. doi: 10.1002/cmdc.201500318. Epub 2015 Sep 7.

Abstract

Basic bulky amines such as amantadine are well-characterized M2 channel blockers, useful for treating influenza. Herein we report our surprising findings that charge-neutral, bulky isocyanides exhibit activities similar to--or even higher than--that of amantadine. We also demonstrate that these isocyanides have potent growth inhibitory activity against the H5N1 virus. The -NH2 to -N≡C group replacement within current anti-influenza drugs was found to give compounds with high activities at low-micromolar concentrations. For example, a tenfold improvement in potency was observed for 1-isocyanoadamantane (27), with an EC50 value of 0.487 μm against amantadine-sensitive H5N1 virus as determined by both MTT and plaque-reduction assays, without showing cytotoxicity. Furthermore, the isocyanide analogues synthesized in this study did not inhibit the V27A or S31N mutant M2 ion channels, according to electrophysiology experiments, and did not exhibit activity against amantadine-resistant virus strains.

Keywords: M2 channels; amantadines; antiviral agents; influenza; inhibitors; isocyanides.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antiviral Agents / chemical synthesis
  • Antiviral Agents / chemistry
  • Antiviral Agents / pharmacology*
  • Cyanides / chemical synthesis
  • Cyanides / chemistry
  • Cyanides / pharmacology*
  • Dogs
  • Dose-Response Relationship, Drug
  • Influenza A Virus, H5N1 Subtype / drug effects*
  • Influenza A Virus, H5N1 Subtype / growth & development
  • Influenza A Virus, H5N1 Subtype / metabolism
  • Madin Darby Canine Kidney Cells / microbiology
  • Microbial Sensitivity Tests
  • Structure-Activity Relationship
  • Viral Matrix Proteins / antagonists & inhibitors*
  • Viral Matrix Proteins / metabolism

Substances

  • Antiviral Agents
  • Cyanides
  • M2 protein, Influenza A virus
  • Viral Matrix Proteins